Brian Harel is a neuropsychologist at CogState, a company that specializes in the application of conventional and computerized tests of cognition for the purposes of quantifying drug efficacy/toxicity in human subjects in clinical drug trials, concussion management, and cognitive screening. Brian’s expertise is in the area of identification and measurement of subtle behavioral and cognitive dysfunction, particularly secondary to treatment-associated toxicity in oncology.
Prior to earning his law degree, Brian obtained his undergraduate degree in neuroscience from Trinity College in Hartford, CT. He then spent several years as a researcher in genetic epidemiology at Yale School of Medicine before attending the University of Connecticut where he obtained his PhD in clinical neuropsychology. He completed his internship at Ann Arbor Veterans Affairs Medical Center/University of Michigan Health System and his postdoctoral residency at the University of Iowa Hospitals and Clinics, Department of Neurology.
Brian earned his J.D., summa cum laude, from Arizona State University’s Sandra Day O’Connor College of Law and was a Pedrick Scholar and a Center Scholar of the Center for Law, Science & Innovation. Brian was also awarded the Daniel Strouse Prize, Fay T Runyan Scholarship and certificates in Law, Science & Innovation with a specialization in health law and Health Care Compliance.